National Records of Scotland

Preserving the past, Recording the present, Informing the future

Deaths involving COVID-19 Week 04: 24 - 30 January 2022

Deaths involving COVID-19 Week 04: 24 - 30 January 2022

Wednesday, 2 Feb 2022
covid news release image

As at 30 January  2022, 12,946 deaths have been registered in Scotland where the novel coronavirus (COVID-19) was mentioned on the death certificate, according to statistics published today by National Records of Scotland (NRS).

In the week 24 to 30 January, 121 deaths were registered that mentioned COVID-19 on the death certificate, a decrease of 25 deaths from the previous week.

15 deaths were aged under 65, 22 were aged 65-74 and there were 84 deaths in people aged 75 or over.

Glasgow City (16 deaths), Fife (13 deaths) and North Lanarkshire (12 deaths) had the highest numbers of deaths at council level. In total, 29 (out of 32) council areas had at least one death last week.

75 deaths were in hospitals, 35 were in care homes, 10 were at home or in a non-institutional setting and there was one death in another institutional setting.

Pete Whitehouse, Director of Statistical Services, said:

“The latest figures show that last week there were 121 deaths where COVID-19 was mentioned on the death certificate. This is 25 fewer deaths than the previous week.

“The number of deaths from all causes registered in Scotland in this week was 1,248, which is 8% fewer than the five year average.”

The publication Deaths involving coronavirus (COVID-19) in Scotland is available on the NRS website.

graph showing covid-19 deaths per week

Background

NRS figures include deaths where ‘suspected’ or ‘probable’ COVID-19 appears on the death certificate.

Data are provisional and subject to change in future weekly publications. The 2021 data will be finalised in summer 2022.

Media enquiries should be directed to:
Donna Green
NRS Communications
Tel: 07775-027-380
Email: [email protected]

Further information about the statistics is available from:
NRS Customer Services
Email: [email protected]

Tags: